FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients

被引:10
作者
Georgina Turcott, Jenny [1 ]
Onate-Ocana, Luis F. [2 ]
Soca-Chafre, Giovanny [3 ]
Ramirez-Tirado, Laura-Alejandra [3 ]
Flores-Estrada, Diana [1 ]
Lucia Zatarain-Barron, Zyanya [1 ]
Arrieta, Oscar [1 ]
机构
[1] Natl Canc Inst Mexico INCan, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Natl Canc Inst Mexico INCan, Div Surg, Clin Res Div, Mexico City, DF, Mexico
[3] Natl Canc Inst Mexico INCan, Expt Oncol Lab, Mexico City, DF, Mexico
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2019年 / 71卷 / 03期
关键词
QUALITY-OF-LIFE; NUTRITIONAL-STATUS; ASSOCIATION; VALIDATION; ANAMORELIN; PROGNOSIS; THERAPY; DISEASE; IMPACT;
D O I
10.1080/01635581.2018.1506488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer (LC) has a high rate of anorexia, which negatively affects quality-of-life and prognosis; however prevalence values may vary as per diagnostic test. There is no standard for anorexia diagnosis, currently the anorexia cachexia scale (A/CS) has been proposed as a tool for diagnosing anorexia with a consensus cutoff value of <= 24, nonetheless a validated cutoff value is required. The A/CS was evaluated in advanced Non-Small Cell Lung Cancer (NSCLC) patients to establish a cutoff value. The appetite item from the QLQ-C30 questionnaire and survival served as a standard reference. The cutoff value was associated with clinical and nutritional characteristics along with quality-of-life. Three hundred and twelve (312) NSCLC patients were evaluated. The mean A/CS value was 31 +/- 9 and the identified cutoff value was 32.5 (sensitivity: 80.3% and specificity: 85%). The proportion of anorexia accurately diagnosed with the cutoff value of 24 was 26%, while with 32 it was 50%. The A/CS cutoff value of 32 was associated with clinical parameters, nutritional consumption, and quality-of-life, and independently associated with overall survival. A score of <= 32 in the A/CS is proposed for anorexia diagnosis in order to identify patients at risk of complications involving malnutrition related to LC.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 50 条
  • [21] A Meta Analysis on Prognostic Value of Patients with Non-Small Cell Lung Cancer
    Rui, Jiang
    Li Yingping
    Gu, Lijun
    Wang, Zhiyan
    Zuo, Jing
    Zha, Lin
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2018, 8 (09) : 1875 - 1880
  • [22] Value of prognostic nutritional index in patients with non-small cell lung cancer
    Kabadayi, Feyyaz
    Akbay, Makbule Oezlem
    Akturk, Ulkue Aka
    Ernam, Dilek
    EURASIAN JOURNAL OF PULMONOLOGY, 2023, 25 (02) : 107 - 115
  • [23] Spirometry at diagnosis and overall survival in non-small cell lung cancer patients
    Zhai, Ting
    Li, Yi
    Brown, Robert
    Lanuti, Michael
    Gainor, Justin F.
    Christiani, David C.
    CANCER MEDICINE, 2022, 11 (24): : 4796 - 4805
  • [24] A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer
    Lu, Ping
    Ma, Yifei
    Kai, Jindan
    Wang, Jun
    Yin, Zhucheng
    Xu, Hongli
    Li, Xinying
    Liang, Xin
    Wei, Shaozhong
    Liang, Xinjun
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [25] Quality of life in patients with advanced non-small cell lung cancer
    Bozcuk, Hakan
    Dalmis, Berna
    Samur, Mustafa
    Ozdogan, Mustafa
    Artac, Mehmet
    Savas, Burhan
    CANCER NURSING, 2006, 29 (02) : 104 - 110
  • [26] Prognostic value of histology in patients with non-small cell lung cancer
    Charloux, A
    Hedelin, G
    Dietemann, A
    Ifoundza, T
    Roeslin, N
    Pauli, G
    Quoix, E
    LUNG CANCER, 1997, 17 (01) : 123 - 134
  • [27] Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A
    Miura, Keita
    Shukuya, Takehito
    Furuya, Naoki
    Morita, Ryo
    Kisohara, Akira
    Mouri, Atsuto
    Watanabe, Satoshi
    Tanaka, Hisashi
    Hirata, Aya
    Hakozaki, Taiki
    Hamai, Kosuke
    Matsumoto, Naoko
    Watanabe, Kana
    Ashinuma, Hironori
    Miyauchi, Eisaku
    Sugano, Koji
    Hosokawa, Shinobu
    Amano, Koji
    Morita, Satoshi
    Kobayashi, Kunihiko
    Maemonodo, Makoto
    Takahashi, Kazuhisa
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, : 2618 - 2628
  • [28] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [29] Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients
    Jiang, Da
    Shi, Jian
    Yuan, Meng
    Duan, Xiaoyang
    Li, Lihua
    Li, Qian
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (06) : 71 - 76
  • [30] Predictors of efficacy of anamorelin in patients with non-small cell lung cancer and cachexia: A retrospective study
    Ishioka, Yoshiko
    Tanaka, Hisashi
    Makiguchi, Tomonori
    Fujishima, Syunsuke
    Nunomura, Yasuhito
    Sakamoto, Hiroaki
    Shiratori, Toshihiro
    Taima, Kageaki
    Tasaka, Sadatomo
    ONCOLOGY LETTERS, 2024, 27 (01)